Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human FACE1/ZMPSTE24 Protein, N-His

Catalog #:   YHB32901 Specific References (27) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: O75844
Protein length: Asp217-Lys347
Overview

Catalog No.

YHB32901

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Asp217-Lys347

Predicted molecular weight

17.33 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

O75844

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

FACE-1, Prenyl protein-specific endoprotease 1, CAAX prenyl protease 1 homolog, Farnesylated proteins-converting enzyme 1, Zinc metalloproteinase Ste24 homolog, FACE1, STE24, ZMPSTE24

Data Image
  • SDS-PAGE
    SDS-PAGE for Recombinant Human FACE1/ZMPSTE24 protein
References

Structure Bioinformatics of Six Human Integral Transmembrane Enzymes and their AlphaFold3 Predicted Water-Soluble QTY Analogs: Insights into FACE1 and STEA4 Binding Mechanisms., PMID:39966220

Cell Surface B2m-Free Human Leukocyte Antigen (HLA) Monomers and Dimers: Are They Neo-HLA Class and Proto-HLA?, PMID:37627243

Predicting Multi-Interfacial Binding Mechanisms of NLRP3 and ASC Pyrin Domains in Inflammasome Activation., PMID:33504150

Mandibuloacral dysplasia type B (MADB): a cohort of eight patients from Suriname with a homozygous founder mutation in ZMPSTE24 (FACE1), clinical diagnostic criteria and management guidelines., PMID:31856865

MicroRNAs in hereditary and sporadic premature aging syndromes and other laminopathies., PMID:29696758

Mandibuloacral dysplasia: A premature ageing disease with aspects of physiological ageing., PMID:29208544

New ZMPSTE24 (FACE1) mutations in patients affected with restrictive dermopathy or related progeroid syndromes and mutation update., PMID:24169522

A novel family of soluble minimal scaffolds provides structural insight into the catalytic domains of integral membrane metallopeptidases., PMID:23733187

Indoxyl sulfate promotes vascular smooth muscle cell senescence with upregulation of p53, p21, and prelamin A through oxidative stress., PMID:22555846

Activated protein C cofactor function of protein S: a novel role for a γ-carboxyglutamic acid residue., PMID:21508412

Insulin-like growth factor 1 treatment extends longevity in a mouse model of human premature aging by restoring somatotroph axis function., PMID:20805469

Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging., PMID:20458013

HIV protease inhibitors inhibit FACE1/ZMPSTE24: a mechanism for acquired lipodystrophy in patients on highly active antiretroviral therapy?, PMID:20074077

[The role of parotid gland biopsy in early detection of lymphoma in primary Sjogren's syndrome]., PMID:19663187

Microcephalia with mandibular and dental dysplasia in adult Zmpste24-deficient mice., PMID:19014358

[A-type lamins and progeroïd syndromes : persistent farnesylation with dramatic effects]., PMID:18950579

Accumulation of multiple forms of lamin A with down-regulation of FACE-1 suppresses growth in senescent human cells., PMID:17352743

Midfacial degloving--access to nasal cavity and paranasal sinuses lesions., PMID:16951847

Homozygous and compound heterozygous mutations in ZMPSTE24 cause the laminopathy restrictive dermopathy., PMID:16297189

From immature lamin to premature aging: molecular pathways and therapeutic opportunities., PMID:16258283

Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation., PMID:16079796

Loss of ZMPSTE24 (FACE-1) causes autosomal recessive restrictive dermopathy and accumulation of Lamin A precursors., PMID:15843403

RNAi of FACE1 protease results in growth inhibition of human cells expressing lamin A: implications for Hutchinson-Gilford progeria syndrome., PMID:15671064

Prelamin A endoproteolytic processing in vitro by recombinant Zmpste24., PMID:15479156

Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy., PMID:15317753

Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice., PMID:11923874

Identification and chromosomal location of two human genes encoding enzymes potentially involved in proteolytic maturation of farnesylated proteins., PMID:10373325

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human FACE1/ZMPSTE24 Protein, N-His [YHB32901]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only